Comunicado de la FDA sobre la seguridad de los medicamentos: Ritmos cardíacos anormales asociados con dosis altas de Celexa (bromhidrato de citalopram)
El 24 de agosto de 2011 la Administración de Alimentos y Medicamentos de los EE. UU. (FDA) informó a los profesionales de la salud y los pacientes que el antidepresivo Celexa (bromhidrato de citalopram, también comercializado como genérico) ya no debe utilizarse en dosis superiores a 40 mg por dÃa ya que puede causar cambios anormales en la actividad eléctrica del corazón. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - February 29, 2016 Category: Drugs & Pharmacology Source Type: news
What I Learn on the Orange Couch: Creating Boundaries for the First Time
(Stitching by Alisa Burke) His shoes are almost always brown. Sometimes, like last week, his socks match his bright green jacket, which I think is worn on days with rain. But I can't be sure; my evidence is sketchy, inconsistent, and random. I sit across from him, on a nubby burnt orange sofa that feels sturdy and new-ish and is so dark it is almost red; it is long enough for a family of four, depending on the capacity of that family for closeness. Which, perhaps, is the point in his line of work. In May of last year, I started seeing a psychiatrist; it is time for us to shed the stigma that rides alongside mental healt...
Source: Healthy Living - The Huffington Post - February 19, 2016 Category: Consumer Health News Source Type: news
Antidepressants have been a lifesaver for me
Medicated depressives may kill themselves - but the unmedicated ones are far more likely to do so. It's dangerous to just dismiss these drugs (Source: Telegraph Health)
Source: Telegraph Health - January 28, 2016 Category: Consumer Health News Tags: antidepressants depression prescription clinical trials citalopram rates suicide side effects studies overprescription Britain Source Type: news
Comunicado de la FDA sobre la seguridad de los medicamentos: Recomendaciones modificadas para Celexa (citalopram bromhidrato) relacionadas con el riesgo potencial de ritmo cardiaco anormal con dosis altas
El 28 de marzo del 2012, la Administración de Alimentos y Medicamentos de Estados Unidos (FDA por sus siglas en inglés) clarificó recomendaciones sobre dosis y advertencias para el antidepresivo Celexa (citalopram bromhidrato; también disponible como medicamento genérico). (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - January 19, 2016 Category: Drugs & Pharmacology Source Type: news
Talking therapy 'as effective as antidepressants' study finds
ConclusionPrevious research has shown that both second generation antidepressants and CBT can be helpful for people with depression. This study found that they seem to work about as well as each other.The study has many strengths, including the fact it is a systematic review, and includes information from RCTs involving more than 1,500 people. However, the studies don't give us much information about adverse effects of treatments, or who responds best to which type of treatment. This is important, because what works for one person may not work as well for another. Some doctors think people with severe depression need to be...
Source: NHS News Feed - December 10, 2015 Category: Consumer Health News Tags: Mental health Medical practice Source Type: news
Cortisol supplement combined with psychotherapy and citalopram improves depression outcomes in patients with hypocortisolism after traumatic brain injury - Luo L, Chai Y, Jiang R, Chen X, Yan T.
Depression is one of the most prevalent psychiatric disorders in people with Traumatic brain injury (TBI). Depression after TBI is closely related with social and psychological factors and hypothalamic-pituitary -adrenal (HPA) axis dysfunction. However, th... (Source: SafetyLit: All (Unduplicated))
Source: SafetyLit: All (Unduplicated) - December 4, 2015 Category: Global & Universal Tags: Alcohol and Other Drugs Source Type: news
Antidepressant paroxetine study 'under-reported data on harms'
ConclusionThis study stands as a warning about how supposedly neutral scientific research papers may mislead readers by presenting findings in a certain way.The differences between the independent analysis published in the BMJ and the 2001 research paper are stark. They cannot both be right. The "authors" of the 2001 paper appear to have picked outcome measures to suit their results, in the way they present evidence of effectiveness. It has subsequently come to light that the first draft paper was not actually written by the 22 academics named on the paper, but by a "ghostwriter" paid by GSK.The study ...
Source: NHS News Feed - September 17, 2015 Category: Consumer Health News Tags: Medical practice Medication Mental health Pregnancy/child Source Type: news
Case report: veno-venous ECMO as a bridge to lung transplantation in paraquat poisoning
3 out of 5 stars
Successful extracorporeal membrane oxygenation therapy as a bridge to sequential bilateral lung transplantation for a patient after severe paraquat poisoning. Tang X et al. Clin Toxicol 2015 Aug 28 [Epub ahead of print]
Abstract
Conceptually, extracorporeal membrane oxygenation (ECMO) seems a perfect technique for treating some of the sickest toxicology patients, buying time until failing vital functions can recover.
With severe cardiotoxins — for example, calcium channel blockers, beta blockers or bupropion — veno-arterial ECMO can provide complete cardiopulmonary bypass, replacing both cardiac a...
Source: The Poison Review - September 9, 2015 Category: Toxicology Authors: Leon Tags: Medical ECMO extracorporeal membrane oxygenation lung transplantation paraquat poisoning Source Type: news
Living with Panic Attacks
You’re sitting in your car trying to will yourself to walk into the grocery store. Anxiety washes over you. You’re cold and hot at the same time with sweat trickling down your back, hair standing on your arms. You finally get out of your car. But as you enter the store, you feel wobbly and like you’re going to pass out. The fluorescent lighting seems especially stifling. The wide aisles, oddly enough, feel claustrophobic. Your breath feels finite, like a balloon floating up to the sky, which you can’t catch. In fact, at times you feel like you’re floating along with the balloon. At times you feel like Edvard Munc...
Source: Psych Central - September 3, 2015 Category: Psychiatry Authors: Margarita Tartakovsky, M.S. Tags: Anxiety Cognitive-Behavioral Disorders General Psychotherapy Relaxation and Meditation Self-Esteem Self-Help Stress Academy of Cognitive Therapy Agoraphobia Antidepressant Anxiety Disorder Association for Behavioral and Cognitive Source Type: news
Vortioxetine in depression: No hint of added benefit
A review of the drug Vortioxetine has concluded that there is no suitable data for acute treatment or for relapse prevention. The evidence was only partly considered for the indirect comparison with citalopram. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - August 11, 2015 Category: Science Source Type: news
Seven years on, I still can't get off my antidepressants
Doctors failed to warn Clare Marks of possible withdrawal effects when they prescribed her the drugs (Source: The Telegraph : Health Advice)
Source: The Telegraph : Health Advice - August 3, 2015 Category: Consumer Health News Tags: antidepressant depression withdrawal effects health citalopram drugs symptoms Cherrill Hicks adiction doctor Source Type: news
Seven years on, I still can't get off my antidepressants
Doctors failed to warn Clare Marks of possible withdrawal effects when they prescribed her the drugs (Source: Telegraph Health)
Source: Telegraph Health - August 3, 2015 Category: Consumer Health News Tags: antidepressant depression withdrawal effects health citalopram drugs symptoms Cherrill Hicks adiction doctor Source Type: news
How do common medications influence moral decisions?
A recent study shows that medications used to treat depression and Parkinson’s disease can alter moral decision-making in healthy people. Lead author Molly Crockett discusses what we can and cannot conclude from these findings.Can drugs change our morals? My colleagues and I recently addressed this question in a study carried out at University College London. We gave healthy people the opportunity to earn money by delivering painful electric shocks to either themselves or others, and investigated how common medications influence these moral decisions. One group of volunteers received either the serotonin-enhancing antide...
Source: Guardian Unlimited Science - July 13, 2015 Category: Science Authors: Molly Crockett Tags: Science Psychology Neuroscience Source Type: news
New Study Sheds Light On The Link Between Antidepressants And Birth Defects
A new study from the Centers for Disease Control and Prevention finds that pregnant women who take certain drugs that are part of a class of antidepressants known as SSRIs (selective serotonin reuptake inhibitors) are at slightly increased risk for having a baby with birth defects. While this sounds frightening, the absolute risk for birth defects is still very low, cautioned study authors. For instance, women who took Paxil (paroxetine) would increase their risk for giving birth to a baby with anencephaly (a serious and often fatal brain and skull defect) from two per 10,000 to seven per 10,000. For a certain heart ...
Source: Science - The Huffington Post - July 10, 2015 Category: Science Source Type: news
Study links Prozac, Paxil use with birth defects
(Reuters) - A sweeping government study of thousands of women has found links between the older antidepressants Prozac and Paxil and birth defects, but has cleared other popular treatments in the class, including Celexa, Lexapro and Pfizer's Zoloft, which is the subject of a major lawsuit over birth defect claims. (Source: Reuters: Health)
Source: Reuters: Health - July 10, 2015 Category: Consumer Health News Tags: healthNews Source Type: news
